FDA Inspection
AMO (Hangzhou) Co., Ltd.AMO (Hangzhou) Co., Ltd. – FDA Inspection, Jul 2, 2019
Record Details
This FDA Inspection record concerns AMO (Hangzhou) Co., Ltd., with an inspection on July 2, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 28d42ae9-9bc4-468b-9291-bb3b1d2ebf16
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1096712
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of AMO (Hangzhou) Co., Ltd.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| November 5, 2024 | Not classified | Office of Inspections and Investigations | |
| January 13, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 13, 2015 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| August 23, 2012 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for AMO (Hangzhou) Co., Ltd.
- FDA Inspection 1255117 - 2024-11-05
- FDA Inspection 998824 - 2017-01-13
- FDA Inspection 941165 - 2015-08-13
- FDA Inspection 799100 - 2012-08-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.